Breaking News

Sanders eyes subpoena for Novo Nordisk exec on Ozempic, Wegovy prices

June 11, 2024
From today until June 16, you can get 40% off an annual STAT+ subscription and access all of our premium benefits. Sign up here.
courtesy Ottavia Maddaluno

STAT+ | Tweezers? Wrenches? Researchers plot prosthetics' future with tools, not hands

Prosthetic users felt as much personal embodiment with tools like tweezers compared to a "natural" hand in VR testing, new study found.

By Timmy Broderick


Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices

Bernie Sanders first launched an investigation into Novo Nordisk's pricing practices for Ozempic and Wegovy in April.

By Rachel Cohrs Zhang and Elaine Chen


STAT+ | Google's Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app

Verily plans to blend artificial intelligence, weight loss drug prescriptions, and remote monitoring under the banner of Lightpath Metabolic.

By Brittany Trang



Alexander Morris of The Four Tops
Stefan Brending/Wikimedia Commons

Four Tops singer's lawsuit says he visited ER for chest pain, ended up in straitjacket

The Four Tops singer was placed in a straitjacket instead of receiving medical care for his heart attack, he claims in a lawsuit.

By Tara Bannow


Melinda French Gates, going solo, aims to influence reproductive rights in the U.S.

The U.S. has gained a new philanthropic powerhouse — who could dramatically move the needle on reproductive health and women's rights in the U.S.

By Annalisa Merelli


House Republicans press for new guardrails on 'gain-of-function' research by NIH

GOP lawmakers recommended the federal government "remove final review and approval" for so-called gain-of-function research from the NIH.

By Sarah Owermohle


The founders of Syntis Bio, from left to right: Giovanni Traverso, Rahul Dhanda, and Bob Langer.
Courtesy Douglas Levy

STAT+ | Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments

Syntis' core approach is an oral polymer chemistry the team calls SYNT, which creates a coating over receptors in places like the stomach.

By Allison DeAngelis


Opinion: Empathy should guide responses to reported vaccine injuries

Vaccine injuries — long-term medical consequences from a shot — are real phenomena worthy of investigation, and empathy.

By Kizzmekia S. Corbett-Helaire


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments